General Information
Version
2.0
Revision date
2016-05-16
Product name
Dydrogesterone and Estradiol Tablets
Product Synonyms
Estradiol/Dydrogesterone film-coated tablets; Climaston; Femoston; Haruton; Femphascyl; Femoston Conti; Femaston; Femoston Continu; Femoston Low; Femoston Mini; Femoston Mite
1.2.1 Relevant identified uses
Pharmaceutical. Use only as directed. Refer to product insert for usage instructions and product information
Emergency telephone
+1 703-741-5970
Icons in SDS
Company Information
company name
Mylan N.V
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Patients/Consumers: Please refer to the product information insert or product label for appropriate consumer-specific information about this product when used according to the physician’s directions. Pharmaceutical Agent – Handling of this product in its final form presents minimal occupational exposure risk. This product is a pharmaceutical in its final form, for direct administration to the patient. As such, is it within the scope of Directive 2001/83/EC on the Community code for medicinal products for human use. It is therefore exempted from the provisions
Adverse physicochemical, human health and environmental effects
No additional information available
Supplemental label elements
EUH210 - Safety data sheet available on request
Other hazards which do not result in classification
Product is in pill form, but contains substances that are combustible dusts. If these substances in their powder form are allowed to accumulate, dispersed in sufficient quantities in air, and in the presence of an ignition source may cause a dust explosion.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Not classified Adverse physicochemical, human health and environmental effects No additional information available
